Resmed Inc (NYSE: RMD) is -3.92% lower on its value in year-to-date trading and has touched a low of $172.19 and a high of $263.05 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RMD stock was last observed hovering at around $220.22 in the last trading session, with the day’s loss setting it -0.5%.
Currently trading at $219.72, the stock is -4.79% and -6.91% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.17 million and changing -0.23% at the moment leaves the stock -4.44% off its SMA200. RMD registered 15.79% gain for a year compared to 6-month loss of -13.11%. The firm has a 50-day simple moving average (SMA 50) of $236.0172 and a 200-day simple moving average (SMA200) of $229.92.
The stock witnessed a -7.46% gain in the last 1 month and extending the period to 3 months gives it a -10.23%, and is -2.36% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.26% over the week and 2.85% over the month.
Resmed Inc (RMD) has around 9980 employees, a market worth around $32.27B and $4.93B in sales. Current P/E ratio is 25.96 and Fwd P/E is 20.98. Profit margin for the company is 25.35%. Distance from 52-week low is 27.60% and -16.47% from its 52-week high. The company has generated returns on investments over the last 12 months (20.62%).
The EPS is expected to grow by 22.91% this year
1288.0 institutions hold shares in Resmed Inc (RMD), with institutional investors hold 63.30% of the company’s shares. The shares outstanding are 146.86M, and float is at 145.82M with Short Float at 5.99%. Institutions hold 62.82% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 17.9 million shares valued at $3.43 billion. The investor’s holdings represent 12.1805 of the RMD Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.69 million shares valued at $2.24 billion to account for 7.9559 of the shares outstanding. The other top investors are STATE STREET CORP which holds 6.14 million shares representing 4.1825 and valued at over $1.18 billion, while BANK OF NEW YORK MELLON CORP holds 3.9281 of the shares totaling 5.77 million with a market value of $1.11 billion.
Resmed Inc (RMD) Insider Activity
The most recent transaction is an insider sale by Sandercock Brett, the company’s Chief Financial Officer. SEC filings show that Sandercock Brett sold 1,000 shares of the company’s common stock on Mar 10 ’25 at a price of $230.36 per share for a total of $0.23 million. Following the sale, the insider now owns 90864.0 shares.
Resmed Inc disclosed in a document filed with the SEC on Mar 10 ’25 that Ghoshal Kaushik (Chief Commercial Officer, SaaS) sold a total of 9,745 shares of the company’s common stock. The trade occurred on Mar 10 ’25 and was made at $239.31 per share for $2.33 million. Following the transaction, the insider now directly holds 9725.0 shares of the RMD stock.
Still, SEC filings show that on Mar 07 ’25, Farrell Michael J. (Chief Executive Officer) disposed off 8,009 shares at an average price of $229.20 for $1.84 million. The insider now directly holds 455,472 shares of Resmed Inc (RMD).
